A Novel TAL2::TCRB Fusion With PI3K/AKT Pathway Mutations in Pediatric T‐Cell Acute Lymphoblastic Leukemia: Diagnostic and Therapeutic Implications

Documenti analoghi

• Pediatric B‐Cell Acute Lymphoblastic Leukemia With FUS::FLI1 Fusion in an Infant With Measurable Residual Disease: Sustained Molecular Remission Achieved With Blinatumomab
  di: Qiang Yao, et al.
  Pubblicazione: (2025)
• A Rare Case of Acute Leukemia With CBFA2T3::GLIS2 Fusion Exhibiting a T/Megakaryocyte Mixed Phenotype
  di: Qiang Yao, et al.
  Pubblicazione: (2025)
• A Rare Case of Infant B‐ALL With SIN3A::NUTM1 Fusion: Durable Molecular Remission Achieved With Standard Acute Lymphoblastic Leukemia Chemotherapy
  di: Dong Peng, et al.
  Pubblicazione: (2026)
• Sustained Remission in a Pediatric B‐Cell Acute Lymphoblastic Leukemia With Rare PAX5::KIAA1549L Fusion and Complex Karyotype Following Blinatumomab Consolidation
  di: Xiaoyong Chen, et al.
  Pubblicazione: (2025)
• Visceral Fat and Body Fat as Risk Factors for Methotrexate Toxicity in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
  di: Alda Daniela García‐Guzmán, et al.
  Pubblicazione: (2025)